Free Trial

Autonomix Medical (AMIX) Competitors

Autonomix Medical logo
$3.14 +0.28 (+9.79%)
Closing price 01/17/2025 04:00 PM Eastern
Extended Trading
$2.89 -0.25 (-7.96%)
As of 08:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AMIX vs. CTCX, QTI, BTCY, AEMD, CHEK, ICU, POAI, NURO, CUTR, and MHUA

Should you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include Carmell (CTCX), QT Imaging (QTI), Biotricity (BTCY), Aethlon Medical (AEMD), Check-Cap (CHEK), SeaStar Medical (ICU), Predictive Oncology (POAI), NeuroMetrix (NURO), Cutera (CUTR), and Meihua International Medical Technologies (MHUA). These companies are all part of the "medical equipment" industry.

Autonomix Medical vs.

Autonomix Medical (NASDAQ:AMIX) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Autonomix Medical presently has a consensus target price of $28.00, suggesting a potential upside of 791.72%. Given Autonomix Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Autonomix Medical is more favorable than Carmell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Carmell
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$15.43M-$16.07-0.20
CarmellN/AN/A-$15.44MN/AN/A

In the previous week, Autonomix Medical had 2 more articles in the media than Carmell. MarketBeat recorded 4 mentions for Autonomix Medical and 2 mentions for Carmell. Carmell's average media sentiment score of -0.33 beat Autonomix Medical's score of -0.40 indicating that Carmell is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Carmell
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by company insiders. Comparatively, 29.0% of Carmell shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Autonomix Medical received 1 more outperform votes than Carmell when rated by MarketBeat users.

CompanyUnderperformOutperform
Autonomix MedicalOutperform Votes
1
100.00%
Underperform Votes
No Votes
CarmellN/AN/A

Carmell's return on equity of -217.50% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -542.11% -236.92%
Carmell N/A -217.50%-50.22%

Summary

Autonomix Medical beats Carmell on 7 of the 11 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMIX vs. The Competition

MetricAutonomix MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3.62M$4.78B$5.34B$9.11B
Dividend YieldN/A52.58%5.37%4.00%
P/E RatioN/A13.8156.8413.06
Price / SalesN/A58.081,275.3476.04
Price / CashN/A50.8936.6132.89
Price / Book0.397.794.874.58
Net Income-$15.43M$13.87M$118.05M$224.84M
7 Day Performance14.18%2.85%1.47%2.37%
1 Month Performance-12.78%10.48%2.54%4.40%
1 Year PerformanceN/A32.32%25.37%20.10%

Autonomix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMIX
Autonomix Medical
2.4217 of 5 stars
$3.14
+9.8%
$28.00
+791.7%
N/A$3.62MN/A0.001High Trading Volume
CTCX
Carmell
0.6446 of 5 stars
$0.55
+11.1%
N/A-83.7%$11.43M$32,839.000.0014Gap Down
QTI
QT Imaging
N/A$0.48
+5.3%
N/AN/A$10.45M$4.00M0.00N/AGap Down
BTCY
Biotricity
N/A$0.38
-12.8%
N/A-66.0%$9.21M$12.06M-0.2740Gap Down
AEMD
Aethlon Medical
2.0975 of 5 stars
$0.64
-4.8%
$7.00
+1,002.4%
-65.0%$8.87M$570,000.00-0.2310Analyst Forecast
Gap Down
CHEK
Check-Cap
0.2911 of 5 stars
$1.50
-2.0%
N/A-41.8%$8.78MN/A-0.5080Analyst Forecast
News Coverage
Positive News
ICU
SeaStar Medical
0.2025 of 5 stars
$1.95
-2.0%
N/A-89.5%$8.70M$68,000.00-0.172
POAI
Predictive Oncology
1.9506 of 5 stars
$1.28
-5.9%
$3.00
+134.4%
-59.0%$8.53M$1.48M-0.4230
NURO
NeuroMetrix
0.9091 of 5 stars
$4.01
+1.0%
N/A+35.0%$8.19M$3.77M-0.8720Positive News
CUTR
Cutera
1.4186 of 5 stars
$0.40
-12.7%
$3.00
+647.4%
-82.7%$8.10M$155.21M-0.06460Analyst Forecast
Positive News
Gap Down
MHUA
Meihua International Medical Technologies
1.0025 of 5 stars
$0.32
-1.4%
N/A-64.0%$7.97M$94.25M0.00620Positive News

Related Companies and Tools


This page (NASDAQ:AMIX) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners